ClearPoint Neuro, Inc. (CLPT)
ClearPoint Neuro Market Cap : 333.48M for May 18, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Integra LifeSciences Holdings Corp. | 1.097B |
| Stryker Corp. | 120.09B |
| UFP Technologies, Inc. | 1.682B |
| Tandem Diabetes Care, Inc. | 926.51M |
| Abbott Laboratories | 153.06B |
Market Cap Related Metrics
| PS Ratio | 7.869 |
| PEG Ratio | -0.3260 |
| Price to Book Value | 17.70 |
| Price | 11.12 |
| Earnings Yield | -9.07% |
| PEGY Ratio | -0.3260 |